| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura.
|
Blood
|
1977
|
1.62
|
|
2
|
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
|
Cancer
|
1971
|
1.37
|
|
3
|
Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
|
Cancer Treat Rep
|
1979
|
1.36
|
|
4
|
Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).
|
Cancer Res
|
1969
|
1.33
|
|
5
|
Prognostic factors in multiple myeloma.
|
Cancer
|
1975
|
1.29
|
|
6
|
Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura.
|
Semin Hematol
|
1976
|
1.28
|
|
7
|
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
|
Ann Intern Med
|
1973
|
1.27
|
|
8
|
Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.
|
Cancer Treat Rep
|
1982
|
1.08
|
|
9
|
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
|
Cancer Treat Rep
|
1977
|
0.91
|
|
10
|
Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma.
|
Cancer
|
1984
|
0.89
|
|
11
|
5-azacytidine in acute leukemia.
|
Cancer
|
1978
|
0.87
|
|
12
|
Therapy of thrombotic thrombocytopenic purpura: an overview.
|
Semin Thromb Hemost
|
1981
|
0.85
|
|
13
|
Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: a Southwest Oncology Group Study.
|
Cancer
|
1981
|
0.85
|
|
14
|
Macroglobulinemia and malabsorption.
|
Cleve Clin Q
|
1977
|
0.84
|
|
15
|
T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
|
Cancer
|
1976
|
0.83
|
|
16
|
Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults.
|
Cancer Chemother Rep
|
1969
|
0.83
|
|
17
|
Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
|
Am J Clin Oncol
|
1982
|
0.82
|
|
18
|
Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.
|
Arch Intern Med
|
1974
|
0.82
|
|
19
|
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
|
Cancer
|
1982
|
0.81
|
|
20
|
Therapy of adult acute leukemia with daunorubicin and L-asparaginase.
|
Cancer
|
1974
|
0.81
|
|
21
|
Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group.
|
Arch Intern Med
|
1976
|
0.80
|
|
22
|
IgM monoclonal gammopathy. Histopathologic and clinical spectrum.
|
Cleve Clin Q
|
1977
|
0.80
|
|
23
|
High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
|
J Neurooncol
|
1983
|
0.78
|
|
24
|
Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response.
|
Arch Intern Med
|
1974
|
0.78
|
|
25
|
Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
|
Cancer
|
1977
|
0.78
|
|
26
|
VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
|
Cancer Chemother Pharmacol
|
1982
|
0.78
|
|
27
|
Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.
|
Cancer Treat Rep
|
1981
|
0.77
|
|
28
|
Combination 6-mercaptopurine and 6-methylmercaptopurine riboside in the treatment of adult acute leukemia: a Southwest Oncology Group study.
|
Cancer Treat Rep
|
1979
|
0.77
|
|
29
|
Immunotherapy of disseminated renal cell carcinoma with transfer factor.
|
J Urol
|
1977
|
0.77
|
|
30
|
Cyclocytidine chemotherapy for malignant melanoma.
|
Cancer Treat Rep
|
1978
|
0.76
|
|
31
|
Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin.
|
Arch Intern Med
|
1978
|
0.76
|
|
32
|
High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine.
|
Arch Intern Med
|
1985
|
0.75
|
|
33
|
Thrombocytopenic purpura associated with ingestion of acetaminophen (Tylenol).
|
Cleve Clin Q
|
1973
|
0.75
|
|
34
|
Management of adult acute leukemia. A Southwest Oncology Group study.
|
Cancer
|
1983
|
0.75
|
|
35
|
The therapy of malignant melanoma with transfer factor. A preliminary report.
|
Cleve Clin Q
|
1974
|
0.75
|
|
36
|
Successful treatment of bleomycin lung.
|
Cleve Clin Q
|
1980
|
0.75
|
|
37
|
Hepatic artery infusion with 5-fluorouracil and mitomycin-C in metastatic colorectal carcinoma phase II study.
|
Med Pediatr Oncol
|
1982
|
0.75
|
|
38
|
A case of large multilobated cell lymphoma.
|
Am J Clin Pathol
|
1984
|
0.75
|
|
39
|
Leukemia occurring in treated Hodgkin's disease: two neoplasms or one?
|
Cleve Clin Q
|
1979
|
0.75
|
|
40
|
Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.
|
Cancer Treat Rep
|
1977
|
0.75
|
|
41
|
Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
|
Cancer Clin Trials
|
1980
|
0.75
|
|
42
|
Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
|
Cancer Treat Rep
|
1979
|
0.75
|
|
43
|
Mast cells in aplastic anemia.
|
Hum Pathol
|
1979
|
0.75
|
|
44
|
Prognostic factors affecting remission, remission duration, and survival in adult acute nonlymphocytic leukemia.
|
Cancer
|
1979
|
0.75
|
|
45
|
Adriamycin therapy in previously treated adult acute leukemia.
|
Cancer Treat Rep
|
1977
|
0.75
|
|
46
|
Case report. Aplastic anemia. Effect of antithymocyte globulin on erythroid colony formation.
|
Cleve Clin Q
|
1978
|
0.75
|
|
47
|
Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
|
Cancer
|
1976
|
0.75
|
|
48
|
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
|
J Clin Oncol
|
1989
|
0.75
|
|
49
|
SPLEEN/PATHOL.
|
Am J Clin Pathol
|
1976
|
0.75
|
|
50
|
Treatment of severe aplastic anemia with antithymocyte globulin.
|
Exp Hematol
|
1982
|
0.75
|
|
51
|
Doxorubicin and ifosfamide combination chemotherapy in previously treated acute leukemia in adults: a Southwest Oncology Group pilot study.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
52
|
Adult acute leukemia studies utilizing cytarabine: early Southwest Oncology Group trials.
|
Med Pediatr Oncol
|
1982
|
0.75
|
|
53
|
Renal manifestations in multiple myeloma and in primary amyloidosis.
|
Cleve Clin Q
|
1970
|
0.75
|
|
54
|
Randomized controlled trial of transfer factor in Stage II malignant melanoma.
|
Cancer
|
1983
|
0.75
|
|
55
|
Intermittent guanazole therapy in adult acute leukemia.
|
Clin Pharmacol Ther
|
1973
|
0.75
|
|
56
|
Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors.
|
J Neurooncol
|
1992
|
0.75
|